# OnCo record enliven (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/enliven/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "enliven", "NCT02371369" ;
  schema:name "ENLIVEN"@en ;
  schema:description "The CSF1R blocker pexidartinib shrank tenosynovial giant cell tumours in about four in ten patients against none on placebo, becoming the first approved drug for this joint tumour, with a liver-safety programme attached."@en ;
  schema:url <https://onco.cc/trials/enliven/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02371369>, <https://doi.org/10.1016/S0140-6736(19)30764-0> ;
  onco:status "positive" ;
  onco:tag "subtype-page" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/tenosynovial-giant-cell-tumour/>, <https://onco.cc/cancers/sarcoma/> ;
  onco:targets <https://onco.cc/targets/csf1r/> ;
  onco:drugs <https://onco.cc/drugs/pexidartinib/> .